0 0 0

This CD22 Approach Highlights the Importance of Experimental Medicine - and Collaboration

Despite a promising approach for certain leukemia patients, the path to market appears to be in question.

The therapy was developed at the National Cancer Institute, and Dr. Mackall said researchers did not know if a company would try to bring...…

Read More…

0 0 1

Jay Galeota joins the Melinta Therapeutics Board

Exciting leadership developments at Melinta!

The board will also be comprised of former board members from Melinta and Cempra as well as the addition of Jay Galeota, a pharmaceutical...…

Read More…

As a free user, you can follow Passle and like posts.

To repost this post to your own Passle blog, you will need to upgrade your account.

For plans and pricing, please contact our sales team at sales@passle.net

Sorry, you don't have permission to repost or create posts.

Repost successful!

View the repost

Repost successful!

Your repost is currently a draft. Review your repost and request approval.

Something went wrong whilst reposting - please try again.

Sorry - this is not an option. This post already exists in the Passle you have selected.

Try reposting to another Passle.